CuroGens Europa IVS: Financial statements 2017
CVR: 37602736
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
CuroGens Europa IVS (CVR 37602736) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 2,620,660 and a net result of DKK 205,904. The profit margin was 7.9%. Equity in the 2017 report amounted to DKK 206,004. The solvency ratio was 57.5%.
- Revenue
- DKK 2,620,660
- Gross Profit
- DKK 257,313
- Profit/Loss
- DKK 205,904
- Equity
- DKK 206,004
- Total Assets
- DKK 358,473
Official annual report
Keep an eye on CuroGens Europa IVS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
CuroGens Europa IVS has published its interim report for the period April 1, 2016 to December 31, 2016.
About CuroGens Europa IVS
CuroGens Europa IVS was a Danish company of the type Iværksætterselskab based in Aarhus C, founded in 2016. The company has been dissolved on 20 December 2021. The company was registered under the industry Konsulentbistand vedrørende informationsteknologi. The company has 1 employee (2020). In 2020, the company reported revenue of DKK 1,824,494 and a net result of DKK 15,632 compared with DKK -57,502 the year before. Equity in the 2020 report amounted to DKK 44,407.
